Registro:

Referencias:

• Andersen, S.L., Gazzara, R.A., Effects of (-)-sulpiride on dopamine release in striatum of developing rats: Degree of depolarization influences responsiveness (1996) J. Neurochem., 67 (5), pp. 1931-1937
• Austin, M.-P.V., Mitchell, P.B., Psychotropic medications in pregnant women: Treatment dilemmas (1998) Med. J. Aust. (Australia), 169, pp. 428-431
• Baldessarini, R.J., Tarazi, F.I., Drugs and the treatment of psychiatric disorders: Psychosis and mania (2001) The Pharmacological Basis of Therapeutics Tenth Edition, pp. 485-519. , J.G. Hardman, L.E. Limbird, & A. Goodman Gilman. New York: MacGraw-Hill. Chapter 20
• Barik, S., Beaurepaire, R., Evidence for a functional role of the dopamine D3 receptors in the cerebellum (1996) Brain Res., 737 (12), pp. 347-350
• Brusés, J.L., Azcurra, J.M., The circling training: A behavioral paradigm for functional teratology testing (1993) Paradigms for the Study of Behavior Methods Neurosci., 14, pp. 166-179. , P.M. Conn. New York: Academic Press
• Brusés, J.L., Berninsone, P.M., Ojea, S., Azcurra, J.M., The circling training rat model as a behavioral teratology test (1991) Pharmacol. Biochem. Behav., 38, pp. 739-745
• Burger, J., Gochfield, M., Lead and neurobehavioral development in gulls: A model for understanding effects in the laboratory and the field (1997) Neurotoxicology, 18 (2), pp. 495-506
• Burke, R.E., Postnatal developmental programmed cell death in dopamine neurons (2003) Ann. N.Y. Acad. Sci., 991, pp. 69-79
• Cagiano, R., Barfield, R.J., White, N.R., Pleim, E.T., Weinstein, M., Cuomo, V., Subtle behavioral changes produced in rat pups by in utero exposure to haloperidol (1988) Eur. J. Pharmacol., 157 (1), pp. 45-50
• Calabresi, P., De Murtas, M., Mercuri, N.B., Bernardi, G., Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission (1992) Ann. Neurol., 31 (4), pp. 366-373
• Castro, R., Brito, B., Segovia, J., Martin-Trujillo, J.M., Notario, V., Prenatal haloperidol induces a selective reduction in the expression of plasticity-related genes in neonate rat forebrain (1994) Mol. Brain Res., 26 (12), pp. 74-80
• Chakos, M.H., Shirakawa, O., Lieberman, J., Lee, H., Bilder, R., Tamminga, C., Striatal enlargement in rats chronically treated with neuroleptics (1998) Biol. Psychiatry, 44 (8), pp. 675-684
• Coyle, J.T., Campochiaro, P., Ontogenesis of cholinergic-dopaminergic interactions in the rat striatum: A neurochemical study (1976) J. Neurochem., 27, pp. 673-678
• Creese, I., Burt, D., Snyder, S.H., Dopamine receptor binding predicts clinical and pharmacological potencies of anti-schizophrenic drugs (1976) Science, 192, pp. 481-483
• Cuomo, V., Perinatal neurotoxicology of psychotropic drugs (1987) Trends Pharmacol. Sci., 8, pp. 346-350
• Cuomo, V., Cagiano, R., Renna, G., Serinelli, A., Brunello, N., Racagni, G., Comparative evaluation of the behavioral consequences of prenatal and early postnatal exposure to haloperidol in rats (1985) Neurobehav. Toxicol. Teratol., 7 (5), pp. 489-492
• Dean, J.C., Hailey, H., Moore, S.J., Lloyd, D.J., Turnpenny, P.D., Little, J., Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth (2002) J. Med. Genet., 39 (4), pp. 251-259
• Dewey, S.L., Smith, G.S., Logan, J., Brodie, J.D., Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects (1993) Proc. Natl. Acad. Sci. U. S. A., 90, pp. 11816-11820
• Eastwood, S.L., Hefferman, J., Harrison, P.J., Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes (1997) Mol. Psychiatry, 2 (4), pp. 322-329
• Faustman, E.M., Oinenn, G.S., Risk assessment (2001) Casarett and Doull's Toxicology, the Basic Science of Poisons Sixth Edition, pp. 93-94. , C.D. Klassen. New York: McGraw-Hill
• Fox, C.A., Mansour, A., Watson Jr., S.J., The effects of haloperidol on dopamine receptor gene expression (1994) Exp. Neurol., 130 (2), pp. 288-303
• Freed, C.R., Yamamoto, B.K., Regional brain dopamine metabolism: A marker for speed, direction, and posture of moving animals (1985) Science, 229, pp. 62-65
• Galili, R., Mosberg, Gil-Ad, I., Weizman, A., Melamed, E., Offen, D., Haloperidol-induced neurotoxicity. Possible implications for tardive dyskinesia (2000) J. Neural Transm., 107 (4), pp. 479-490
• Gjere, N.A., Psychopharmacology in pregnancy (2001) J. Perinat. Neonatal Nurs., 14 (4), pp. 12-35
• Heyman, G.M., Beer, B., A new approach for evaluating the behavioral effects of antipsychotic drugs (1987) TIPS, 8, pp. 388-393
• Hill, H.F., Engblom, J., Effects of pre- and postnatal haloperidol administration to pregnant and nursing rats on brain catecholamine levels in their offspring (1984) Dev. Pharmacol. Ther., 7, pp. 188-197
• Ibarra, G.R., Paratcha, G.C., Wolansky, M.J., Azcurra, J.M., Co-alteration of dopamine D2 receptor and muscarinic acetylcholine receptor binding in rat striatum after circling training (1996) NeuroReport, 7 (1517), pp. 2491-2494
• Imperato, A., Obiunu, M.C., Gessa, G.L., Is in vivo acetylcholine output under a tonic inhibitory control by dopamine? (1995) J. Neural Transm., Suppl., 45, pp. 91-102
• Iñiguez, C., Calle, F., Marshall, E., Carreres, J., Morphological effects of chronic haloperidol administration on the postnatal development of the rat striatum (1987) Brain Res., 432 (1), pp. 27-34
• Lee, M.H., Rabe, A., Neocortical transplant in the micrencephalic rat brain: Morphology and behavior (1988) Brain Res. Bull., 21 (5), pp. 813-824
• Lescaudron, L., Stein, D.G., Functional recovery following transplants of embryonic brain tissue in rats with lesions of visual, frontal and motor cortex: Problems and prospects for future research (1990) Neuropsychologia, 28 (6), pp. 585-599
• Levant, B., Grigoriadis, D.E., De Souza, E.B., Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors (1995) Eur. J. Pharmacol., 278 (3), pp. 243-247
• Lowry, O.H., Rosebrough, N.J., Lewis Farr, A., Randall, R.J., Protein measurement with Folin phenol reagent (1951) J. Biol. Chem., 158, pp. 265-275
• Marchand, R., Lajoie, L., Histogenesis of the striatopallidal system in the rat: Neurogenesis on its neurons (1986) Neuroscience, 17 (3), pp. 573-590
• Middaugh, L.D., Zemp, J.W., Dopaminergic mediation of long-term behavioral effects of in utero drug exposure (1985) Neurobehav. Toxicol. Teratol., 7, pp. 685-689
• Mihaly, G.W., Morgan, D.J., Placental drug transfer: Effects of gestational age and species (1983) Pharmacol. Ther., 23 (2), pp. 253-266
• Miller, J.C., Friedhoff, A.J., Prenatal neurotransmitter programming of postnatal receptor function (1988) Prog. Brain Res., 73, pp. 491-508
• Mitchell, I.J., Cooper, A.C., Griffiths, M.R., Cooper, A.J., Acute administration of haloperidol induces apoptosis of neurons in the striatum and substantia nigra in the rat (2002) Neuroscience, 109 (1), pp. 89-99
• Nelson, B.K., Evidence for behavioral teratogens in humans (1991) J. Appl. Toxicol., 11 (1), pp. 33-37
• Rodier, P., Chronology of neuron development: Animal studies and their clinical implications (1980) Dev. Med. Child Neurol., 22 (4), pp. 525-545
• Rogue, P., Hanauer, A., Zwiller, J., Malaviya, A.N., Vincendon, G., Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment (1991) Eur. J. Pharmacol., 207 (2), pp. 165-168
• Rosengarten, H., Friedhoff, A.J., Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats (1979) Science, 203, pp. 1133-1135
• Russi, G., Girotti, P., Cadoni, P., Di Chiara, G., Consolo, S., Neuroleptics increase striatal acetylcholine release by a sequential D1 and D2 receptor mechanism (1993) NeuroReport, 4, pp. 1335-1338
• Saleh, M.I., Kostrzewa, R.M., MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny (1989) Peptides, 10 (1), pp. 35-39
• Shimohira, M., Iwakawa, Y., Kohyama, J., Rapid-eye-movement sleep in jittery infants (2002) Early Hum. Dev., 66 (1), pp. 25-31
• Singh, K.P., Singh, M., Effect of prenatal haloperidol exposure on behavioral alteration in rats (2002) Neurotoxicol. Teratol., 24 (4), pp. 497-502
• Soiza-Reilly, M., Fossati, M., Ibarra, G.R., Azcurra, J.M., Different dopamine D1 and D2 receptors expression after motor activity in the striatal critical period (2004) Brain Res., 1004 (12), pp. 217-221
• Spear, L.P., The adolescent brain and age-related behavioral manifestations (2000) Neurosci. Biobehav. Rev., 24, pp. 417-463
• Spear, L.P., File, S.E., Methodological considerations in neurobehavioral teratology (1996) Pharmacol. Biochem. Behav., 55 (4), pp. 455-477
• Spear, L.P., Scalzo, F.M., Behavioral, psychopharmacological and neurochemical effects of chronic neuroleptic treatment during development (1986) Handbook of Behavioral Teratology, pp. 173-184. , E.P. Riley, & C.V. Vorhees. New York: Plenum. Chapter 8
• Spigset, O., Haag, S., Excretion of psychotropic drugs into breast milk: Pharmacokinetic overview and therapeutic implications (1998) CNS Drugs, 9, pp. 111-134
• Srivastava, L.K., Morency, M.A., Mishra, R.K., Ontogeny of dopamine D2 receptor mRNA in rat brain (1992) Eur. J. Pharmacol., 225 (2), pp. 143-150
• Streissguth, A.P., Treder, R.P., Barr, H.M., Shepard, T.H., Bleyer, W.A., Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements (1987) Teratology, 35 (2), pp. 211-219
• Swaab, D.F., Mirmiran, M., The influence of chemicals and environment on brain development: "behavioral teratology" (1985) Prog. Clin. Biol. Res., 163, pp. 447-451
• Tang, K.-C., Low, M.J., Grandy, D.K., Lovinger, D.M., Dopamine-dependent synaptic plasticity in striatum during in vivo development (2001) Proc. Natl. Acad. Sci. U. S. A., 98 (3), pp. 1255-1260
• Teischer, M.H., Andersen, S.L., Hostetter Jr., J.C., Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens (1995) Dev. Brain Res., 89 (2), pp. 167-172
• Thomas, J.D., Fleming, S.L., Riley, E.P., Administration of low doses of MK-801 during ethanol withdrawal in the developing rat pup attenuates alcohol's teratogenic effects (2002) Alcohol., Clin. Exp. Res., 26 (8), pp. 1307-1313
• Tilson, H.A., The concern for developmental neurotoxicology: Is it justified and what is being done about it? (1995) Environ. Health Perspect., 103 (SUPPL. 6), pp. 147-151
• Van Vulpen, E.H., Van Der Kooy, D., Striatal cholinergic interneurons: Birthdates predict compartmental localization (1998) Dev. Brain Res., 109 (1), pp. 51-58
• Vorhees, C.V., Developmental neurotoxicity induced by therapeutic and illicit drugs (1994) Environ. Health Perspect., 102 (SUPPL. 2), pp. 145-153
• Vorhees, C.V., Molinow, E., Behavioral teratogenesis: Long-term influences on behavior from early exposure to environmental agents (1987) Handbook of Infants Development Second Edition, pp. 913-971. , J.D. Osofsky. New York: Wiley
• Watanabe, T., Matsuhashi, K., Takayama, S., Placental and blood-brain barrier transfer following prenatal and postnatal exposures to neuroactive drugs: Relationship with partition coefficient and behavioral teratogenesis (1990) Toxicol. Appl. Pharmacol., 105 (1), pp. 66-77
• Williams, R., Ali, S.F., Scalzo, F.M., Soliman, K., Holson, R.R., Prenatal haloperidol exposure: Effects on brain weights and caudate neurotransmitter levels in rats (1992) Brain Res. Bull., 29 (34), pp. 449-458
• Wolansky, M.J., Mongiat, L., Ibarra, G.R., Paratcha, G.C., Cabrera, R.J., Azcurra, J.M., Reduction of sample size per experimental group and time per agent examined in a sensitive rat model for behavioral teratology screening routines (1999) Third World Congress on Alternatives and Animal Use in the Life Sciences, Bologna, Italy, 29th August-2nd September, 1999 Alternatives to Laboratory Animals (ATLA) (Suppl.), pp. 165A
• Xu, S.X., Monsma, F.J., Sibley, D.R., Creese, I., Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment (1992) Life Sci., 50 (5), pp. 383-396
• Yanai, J., Abu-Roumi, M., Silverman, W.F., Steingart, R.A., Neural grafting as a tool for the study and reversal of neurobehavioral birth defects (1996) Pharmacol. Biochem. Behav., 55 (4), pp. 673-681
• Yoshida, K., Smith, B., Craggs, M., Kumar, R., Neuroleptic drugs in breast-milk: A study of pharmacokinetics and of possible adverse effects in breast-fed infants (1998) Psychol. Med., 28 (1), pp. 81-91

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------